To truly expand CAR T access and prepare for the wave of new T cell-based therapies coming through the pipeline, we must find better ways to manage CRS and ICANS.
The post For Many, CAR T is a Miracle Therapy – We Need to Get it to More Patients appeared first on MedCity News.
